Vertex Pharmaceuticals Inc Strategic Asset Allocation Index

Latest as of June 2026: 28.6%

Vertex Pharmaceuticals Inc strategic asset allocation index. Vertex Pharmaceuticals Inc (VRTX) has a Strategic Asset Allocation Index of 28.6% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $5.79 Billion) total $5.79 Billion, measured against net assets of $20.25 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See VRTX net asset quality index to measure how much of total assets are equity-financed.

SAAI

28.6%
Strategic Assets / Net Assets

Strategic Assets

$5.79 Billion
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$20.25 Billion
USD

Strategic Asset Allocation Index of Vertex Pharmaceuticals Inc (2000–2025)

Strategic asset allocation index of Vertex Pharmaceuticals Inc from 2000 to 2025. This chart shows how Vertex Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 26 annual periods from 2000 to 2025. As of June 2026, the index stands at 28.6%, representing strategic assets of $5.79 Billion against net assets of $20.25 Billion USD. Check VRTX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Vertex Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2000–2025)

Vertex Pharmaceuticals Inc strategic asset allocation index by year from 2000 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Vertex Pharmaceuticals Inc from 2000 to 2025, covering 26 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see VRTX stock market capitalisation.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2025 30.6% $5.71 Billion $- $5.71 Billion $18.67 Billion ▼ -0.5 pp
2024 31.1% $5.11 Billion $- $5.11 Billion $16.41 Billion ▲ +16.9 pp
2023 14.2% $2.50 Billion $- $2.50 Billion $17.58 Billion ▲ +2.9 pp
2022 11.3% $1.57 Billion $1.46 Billion $112.20 Million $13.91 Billion ▲ +0.4 pp
2021 10.8% $1.09 Billion $1.09 Billion $- $10.10 Billion ▼ -0.2 pp
2020 11.0% $958.53 Million $958.53 Million $- $8.69 Billion ▼ -3.7 pp
2019 14.7% $894.08 Million $833.28 Million $60.80 Million $6.09 Billion ▼ -3.9 pp
2018 18.6% $825.61 Million $812.00 Million $13.60 Million $4.44 Billion ▼ -21.0 pp
2017 39.7% $809.88 Million $789.44 Million $20.45 Million $2.04 Billion ▼ -14.0 pp
2016 53.7% $718.64 Million $698.36 Million $20.28 Million $1.34 Billion ▼ -12.9 pp
2015 66.6% $727.72 Million $697.72 Million $30.00 Million $1.09 Billion ▲ +1.4 pp
2014 65.2% $715.81 Million $715.81 Million $- $1.10 Billion ▲ +13.8 pp
2013 51.4% $696.91 Million $696.91 Million $- $1.36 Billion ▲ +16.3 pp
2012 35.1% $433.61 Million $433.61 Million $- $1.23 Billion ▲ +21.3 pp
2011 13.8% $133.18 Million $133.18 Million $- $965.51 Million ▼ -0.6 pp
2010 14.4% $72.33 Million $72.33 Million $- $503.97 Million ▲ +8.7 pp
2009 5.7% $62.28 Million $62.28 Million $- $1.10 Billion ▼ -22.9 pp
2008 28.6% $68.33 Million $68.33 Million $- $238.87 Million ▲ +4.1 pp
2007 24.5% $66.51 Million $66.51 Million $- $271.30 Million ▲ +12.4 pp
2006 12.2% $61.53 Million $61.53 Million $- $505.94 Million ▼ -10.6 pp
2005 22.8% $54.53 Million $54.53 Million $- $239.18 Million ▼ -158.4 pp
2004 181.2% $64.22 Million $64.22 Million $- $35.44 Million ▲ +139.7 pp
2003 41.5% $80.08 Million $80.08 Million $- $192.84 Million ▲ +16.2 pp
2002 25.4% $95.99 Million $95.99 Million $- $378.58 Million ▲ +8.4 pp
2001 16.9% $80.38 Million $80.38 Million $- $475.35 Million ▲ +8.8 pp
2000 8.1% $28.15 Million $28.15 Million $- $345.76 Million —
pp = percentage points